Standout Papers
Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
[19] Receptor-mediated endocytosis of low-density lipoprotein in cultured cells
1983 StandoutNobel
Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fate
2019 StandoutScienceNobel
Diet and Lifestyle Recommendations Revision 2006
2006 Standout
Defensin Promotes the Binding of Lipoprotein(a) to Vascular Matrix
1999
Mechanisms by which lipoprotein lipase alters cellular metabolism of lipoprotein(a), low density lipoprotein, and nascent lipoproteins. Roles for low density lipoprotein receptors and heparan sulfate proteoglycans.
1992
Dietary vitamin E and the attenuation of early lesion development in modified Watanabe rabbits
1992
Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E–deficient mice
1999
Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation.
1995
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
Triglycerides and Cardiovascular Disease
2011
SEC14L2 enables pan-genotype HCV replication in cell culture
2015 StandoutNatureNobel
The oxidation hypothesis of atherosclerosis
1994
Role of oxidatively modified LDL in atherosclerosis
1990
Immune-deficient mice develop typical atherosclerotic fatty streaks when fed an atherogenic diet.
1994
Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro
1999
Impact of Vitamin E supplementation on lipoprotein peroxidation and composition in Type 1 diabetic patients treated with Atorvastatin
2004
Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer
2005
Modified forms of low density lipoprotein affect platelet aggregation
1989
The Metabolic Syndrome and Total and Cardiovascular Disease Mortality in Middle-aged Men
2002 Standout
Low density lipoprotein is protected from oxidation and the progression of atherosclerosis is slowed in cholesterol-fed rabbits by the antioxidant N,N'-diphenyl-phenylenediamine.
1992
High-Density Lipoprotein as a Therapeutic Target
2007
Beyond Cholesterol
1989 Standout
Role of LXRs in control of lipogenesis
2000
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Reactive Nitrogen Intermediates Promote Low Density Lipoprotein Oxidation in Human Atherosclerotic Intima
1997
Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.
1989 Standout
Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials
2003
Minimally modified low density lipoprotein is biologically active in vivo in mice.
1991
Feasibility of using an oleate-rich diet to reduce the susceptibility of low-density lipoprotein to oxidative modification in humans
1991
Continuous Monitoring ofin VztroOxidation of Human Low Density Lipoprotein
1989 Standout
Spontaneous combined hyperlipidemia, coronary heart disease and decreased survival in Dahl salt-sensitive hypertensive rats transgenic for human cholesteryl ester transfer protein
1999
Changing concepts of atherogenesis
2000
The Molecular Mechanism for the Genetic Disorder Familial Defective Apolipoprotein B100
2001
Minimally modified low density lipoprotein stimulates monocyte endothelial interactions.
1990
Protein Nitration in Cardiovascular Diseases
2002
A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease
1995 Standout
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention1European Society of Cardiology, European Atherosclerosis Society, European Society of Hypertension, International Society of Behavioural Medicine, European Society of General Practice/Family Medicine, European Heart Network.1,2Published simultaneously in the European Heart Journal 1998;19:1434–1503 and the Journal of Hypertension (Summary only) 1998;16(10).2
1998
Major Lipids, Apolipoproteins, and Risk of Vascular Disease
2009 Standout
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
The mechanosensory protein MEC-6 is a subunit of the C. elegans touch-cell degenerin channel
2002 StandoutNatureNobel
Antioxidants and Atherosclerotic Heart Disease
1997 Standout
Drug Treatment of Lipid Disorders
1999
Protein Tyrosine Nitration in the Mitochondria from Diabetic Mouse Heart
2003 Nobel
Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production
2004
High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein
1990
Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia
2000
A hydroxyl radical–like species oxidizes cynomolgus monkey artery wall proteins in early diabetic vascular disease
2001
Sphingomyelinase, an Enzyme Implicated in Atherogenesis, Is Present in Atherosclerotic Lesions and Binds to Specific Components of the Subendothelial Extracellular Matrix
1999
Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions.
1997
The Food Standards Agency's antioxidants in food programme – a summary*
2003
Lipoprotein Management in Patients With Cardiometabolic Risk
2008
Antioxidants and disease prevention
1994
Cholesterol Reduction in Cardiovascular Disease — Clinical Benefits and Possible Mechanisms
1995
Role of superoxide in endothelial-cell modification of low-density lipoproteins
1988
Modification of human serum low density lipoprotein by oxidation — Characterization and pathophysiological implications
1987
Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγ
1998 Standout
Efficacy, Safety, and Tolerability of Once-Daily Niacin for the Treatment of Dyslipidemia Associated With Type 2 Diabetes<subtitle>Results of the Assessment of Diabetes Control and Evaluation of the Efficacy of Niaspan Trial</subtitle>
2002
Beta-carotene inhibits atherosclerosis in hypercholesterolemic rabbits.
1995
The SU.VI.MAX Study
2004
Comparison of Once-Daily, niacin Extended-Release/lovastatin with standard doses of atorvastatin and simvastatin (the advicor versus other Cholesterol-Modulating agents trial evaluation [ADVOCATE])
2003
Estrogen plus Progestin and the Risk of Coronary Heart Disease
2003 Standout
Atherosclerosis — An Inflammatory Disease
1999 Standout
Attenuation of diet‐induced atherosclerosis in rabbits with a highly selective 15‐lipoxygenase inhibitor lacking significant antioxidant properties
1997
The Role of Oxidative Stress in the Pathogenesis??of COPD
2005
Effect of Intensive Compared With Moderate Lipid-Lowering Therapy on Progression of Coronary Atherosclerosis
2004 Standout
Mortality in Randomized Trials of Antioxidant Supplements for Primary and Secondary Prevention
2007 Standout
Preservation of the endogenous antioxidants in low density lipoprotein by ascorbate but not probucol during oxidative modification.
1991
Absence of Monocyte Chemoattractant Protein-1 Reduces Atherosclerosis in Low Density Lipoprotein Receptor–Deficient Mice
1998
Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low-density lipoproteins, and contain oxidation-specific lipid-protein adducts.
1991
Characterization of peroxynitrite-oxidized low density lipoprotein binding to human CD36
2001
Gene expression in macrophage-rich human atherosclerotic lesions. 15-lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-protein adducts.
1991
Low Density Lipoprotein Oxidation and Its Pathobiological Significance
1997
Can change in high-density lipoprotein cholesterol levels reduce cardiovascular risk?
2004
The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis
2019 StandoutNature
Meta-Analysis of the Effects of Soy Protein Intake on Serum Lipids
1995 Standout
Atherosclerosis
2000 StandoutNature
Arterial Metabolism of Lipoproteins in Relation to Atherogenesis
1990
Piezo2 senses airway stretch and mediates lung inflation-induced apnoea
2016 StandoutNatureNobel
Autoantibody against oxidised LDL and progression of carotid atherosclerosis
1992 Standout
Metabolic syndrome and coronary angiographic disease progression: the Women’s Angiographic Vitamin & Estrogen trial
2003
Immunohistochemical evidence for the myeloperoxidase/H2O2/halide system in human atherosclerotic lesions
2000
Safety Considerations with Niacin Therapy
2006
Homocysteine and atherosclerosis
1999
Inflammation, metaflammation and immunometabolic disorders
2017 StandoutNature
Atherosclerosis
2001 Standout
Role of oxidized low density lipoprotein in atherogenesis.
1991 Standout
The pathogenesis of atherosclerosis: a perspective for the 1990s
1993 StandoutNature
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Hyperhomocysteinemia: An Independent Risk Factor for Vascular Disease
1991 Standout
Homocysteine and Atherothrombosis
1998 Standout
Effects of Hormone Replacement Therapy and Antioxidant Vitamin Supplements on Coronary Atherosclerosis in Postmenopausal Women
2002
Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis
1998
Homocyst(e)ine, Diet, and Cardiovascular Diseases
1999
Peroxynitrite modification of low‐density lipoprotein leads to recognition by the macrophage scavenger receptor
1993
The Tumor Necrosis Factor Ligand and Receptor Families
1996 StandoutNobel
Homocysteine as a Risk Factor for Vascular Disease
1997
The LDL Receptor Gene: A Mosaic of Exons Shared with Different Proteins
1985 StandoutScienceNobel
A review of the epidemiological evidence for the ‘antioxidant hypothesis’
2004
Dietary antioxidants preserve endothelium-dependent vessel relaxation in cholesterol-fed rabbits.
1993
Atherosclerosis: Scavenger cell receptor shared
1985 StandoutNatureNobel
Receptor-dependent uptake of human chylomicron remnants by cultured skin fibroblasts.
1981
Angiogenesis Inhibitors Endostatin or TNP-470 Reduce Intimal Neovascularization and Plaque Growth in Apolipoprotein E–Deficient Mice
1999
PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE
1975 Standout
Type III Hyperlipoproteinemia: Defective Metabolism of an Abnormal Apolipoprotein E
1981 Science
The Metabolic Syndrome
2003
Antioxidant Vitamin Supplements and Cardiovascular Disease
2004
Effects of Pramlintide on Postprandial Glucose Excursions and Measures of Oxidative Stress in Patients With Type 1 Diabetes
2005
Primary Prevention of Ischemic Stroke
2001
Minimally oxidized low-density lipoprotein induces tissue factor expression in cultured human endothelial cells.
1991
13C-NMR spectroscopy of human atherosclerotic lesions. Relation between fatty acid saturation, cholesteryl ester content, and luminal obstruction.
1994
Effect of probucol dosage on plasma lipid and lipoprotein levels and on protection of low density lipoprotein against in vitro oxidation in humans.
1992
Dietary Recommendations for Children and Adolescents
2005
Evidence for a dominant role of lipoxygenase(s) in the oxidation of LDL by mouse peritoneal macrophages
1991
Defects of receptor-mediated low density lipoprotein catabolism in homozygous familial hypercholesterolemia and hypothyroidism in vivo.
1981
Herpesviruses in Atherosclerosis and Thrombosis
1998
Atherosclerosis: Basic Mechanisms
1995 Standout
Acid-dependent ligand dissociation and recycling of LDL receptor mediated by growth factor homology region
1987 StandoutNatureNobel
Oxidation of human low density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products.
1987
Monoclonal antibodies against LDL further enhance macrophage uptake of LDL aggregates.
1992
Lipoproteins and atherosclerosis. A look back and a look ahead.
1983
Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines.
1985
Atherogenesis: a postprandial phenomenon.
1979 Standout
Effects of Long-term Vitamin E Supplementation on Cardiovascular Events and Cancer
2005
Conditional Vascular Cell Adhesion Molecule 1 Deletion in Mice
2001
Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia.
1987
Lipoprotein lipase and sphingomyelinase synergistically enhance the association of atherogenic lipoproteins with smooth muscle cells and extracellular matrix. A possible mechanism for low density lipoprotein and lipoprotein(a) retention and macrophage foam cell formation.
1993
Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells.
1990
The antioxidant butylated hydroxytoluene protects against atherosclerosis.
1991
Purification of a monocyte chemotactic factor secreted by nonhuman primate vascular cells in culture
1988
Conversion of very low density lipoprotein to low density lipoprotein. A metabolic study of apolipoprotein B kinetics in human subjects.
1975
Regulation of Plasma Cholesterol by Lipoprotein Receptors
1981 StandoutScienceNobel
Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein.
1989 StandoutNobel
Lipoprotein-mediated inhibition of endothelial cell production of platelet-derived growth factor-like protein depends on free radical lipid peroxidation.
1987
Morphology of the endothelium over atherosclerotic plaques in human coronary arteries.
1988
Na+/H+ exchange and cytoplasmic pH in the action of growth factors in human fibroblasts
1983 StandoutNatureNobel
Characterization of a tyrosine-specific kinase activity in human fibroblast membranes stimulated by platelet-derived growth factor.
1982
Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein.
1990
Lowering of HDL 2b by Probucol Partly Explains the Failure of the Drug to Affect Femoral Atherosclerosis in Subjects With Hypercholesterolemia
1995
Vitamin E, LDL, and endothelium. Brief oral vitamin supplementation prevents oxidized LDL-mediated vascular injury in vitro.
1993
Rous-Whipple Award Lecture. Atherosclerosis: a defense mechanism gone awry.
1993
Enzymatically Degraded, Nonoxidized LDL Induces Human Vascular Smooth Muscle Cell Activation, Foam Cell Transformation, and Proliferation
2000
Six-Year Effect of Combined Vitamin C and E Supplementation on Atherosclerotic Progression
2003
Oxidized low density lipoproteins potentiate vasoconstrictions to various agonists by direct interaction with vascular smooth muscle.
1990
Probucol prevents oxidative injury to endothelial cells.
1991
Enhanced macrophage uptake of low density lipoprotein after self-aggregation.
1988
Gas phase oxidants of cigarette smoke induce lipid peroxidation and changes in lipoprotein properties in human blood plasma. Protective effects of ascorbic acid
1991
Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions.
1991
Macrophages, Endothelial Cells, and Lipoprotein Oxidation in the Pathogenesis of Atherosclerosis*
1990
Low density lipoprotein rich in oleic acid is protected against oxidative modification: implications for dietary prevention of atherosclerosis.
1990
Paraoxonase and Atherosclerosis
2001 Standout
AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update
2001
Soluble Vascular Cell Adhesion Molecule-1 as a Biohumoral Correlate of Atherosclerosis
1997
A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein.
1989
Localization of PDGF-B Protein in Macrophages in All Phases of Atherogenesis
1990 Science
Lipid accumulation in rabbit aortic intima 2 hours after bolus infusion of low density lipoprotein. A deep-etch and immunolocalization study of ultrarapidly frozen tissue.
1991
The Yin and Yang of Oxidation in the Development of the Fatty Streak
1996 Standout
Essential role of phospholipase A2 activity in endothelial cell-induced modification of low density lipoprotein.
1985
Oxygen Radicals and Human Disease
1987 Standout
Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis.
1987
Primary Prevention of Ischemic Stroke
2001
Cardiovascular Effects of Secondhand Smoke
2005
Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation.
1984
Guidelines for the Early Management of Patients With Ischemic Stroke
2003
Coronary Plaque Disruption
1995 Standout
Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline
2012
Immunohistochemical detection of macrophages and T lymphocytes in atherosclerotic lesions of cholesterol-fed rabbits.
1991
Oxidation of low-density lipoprotein by thiol compounds leads to its recognition by the acetyl LDL receptor
1987
Circulating Adhesion Molecules VCAM-1, ICAM-1, and E-selectin in Carotid Atherosclerosis and Incident Coronary Heart Disease Cases
1997
Nonenzymatic oxidative cleavage of peptide bonds in apoprotein B-100.
1987
Vitamins C and E Inhibit O 2 − Production in the Pig Coronary Artery
1997
Studies of hypercholesterolemia in the nonhuman primate. II. Fatty streak conversion to fibrous plaque.
1984
The human LDL receptor: A cysteine-rich protein with multiple Alu sequences in its mRNA
1984 StandoutNobel
Atherogenesis during low level hypercholesterolemia in the nonhuman primate. II. Fatty streak conversion to fibrous plaque.
1990
The Response-to-Retention Hypothesis of Early Atherogenesis
1995
O2 Regulates Skeletal Muscle Progenitor Differentiation through Phosphatidylinositol 3-Kinase/AKT Signaling
2011
George Lyman Duff Memorial Lecture. Atherosclerosis: a problem of the biology of arterial wall cells and their interactions with blood components.
1981
Ascorbic acid oxidation product(s) protect human low density lipoprotein against atherogenic modification. Anti- rather than prooxidant activity of vitamin C in the presence of transition metal ions.
1993
Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions.
1990
Platelet factor 4 binds to low-density lipoprotein receptors and disrupts the endocytic itinerary, resulting in retention of low-density lipoprotein on the cell surface
2002 StandoutNobel
Effect of dietary antioxidant combinations in humans. Protection of LDL by vitamin E but not by beta-carotene.
1993
The Pathogenesis of Atherosclerosis: Atherogenesis and Inflammation
1989
Effect of Probucol Treatment on Gene Expression of VCAM-1, MCP-1, and M-CSF in the Aortic Wall of LDL Receptor–Deficient Rabbits During Early Atherogenesis
1997
Prelesional events in atherogenesis. Accumulation of extracellular cholesterol-rich liposomes in the arterial intima and cardiac valves of the hyperlipidemic rabbit.
1986
Increase in the adhesion molecule P-selectin in endothelium overlying atherosclerotic plaques. Coexpression with intercellular adhesion molecule-1.
1994
Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL. Correlation with changes in receptor-mediated catabolism.
1987
Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit.
1987
ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.
1994
Secretory products of macrophages.
1987 Standout
Malondialdehyde-Altered Protein Occurs in Atheroma of Watanabe Heritable Hyperlipidemic Rabbits
1988 Science
The Metabolic Syndrome
2003
Independent Pathways for Secretion of Cholesterol and Apolipoprotein E by Macrophages
1983 StandoutScienceNobel
Role of endothelial cells and their products in the modification of low-density lipoproteins
1986
Macrophage colony-stimulating factor mRNA and protein in atherosclerotic lesions of rabbits and humans.
1992
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
2004 Standout
ESTROGENS AND ATHEROSCLEROSIS
1997
Presence of a modified low density lipoprotein in humans.
1988
The alpha-defensins stimulate proteoglycan-dependent catabolism of low-density lipoprotein by vascular cells: a new class of inflammatory apolipoprotein and a possible contributor to atherogenesis.
2000
Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis.
1988
Antiatherogenic effect of olive and corn oils in cholesterol-fed rabbits with the same plasma cholesterol levels.
1988
Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial
2002
The response‐to‐retention hypothesis of atherogenesis reinforced
1998
AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update
2002
Complete Atherosclerosis Regression After Human ApoE Gene Transfer in ApoE-Deficient/Nude Mice
2000
Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes
1987
Recognition of solubilized apoproteins from delipidated, oxidized low density lipoprotein (LDL) by the acetyl-LDL receptor.
1987
Expression of a disintegrin‐like protein in cultured human vascular cells and in vivo
1997
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
2002 Standout
Lipoproteins and Atherogenesis
1990
Homocyst(e)ine Decreases Bioavailable Nitric Oxide by a Mechanism Involving Glutathione Peroxidase
1997
Familial Dysbetalipoproteinemia: New Aspects of Pathogenesis and Diagnosis
1982
The Pathogenesis of Atherosclerosis — An Update
1986 Standout
AHA Dietary Guidelines
2000
Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
1988 Standout
Effects of oxidatively modified LDL on cholesterol esterification in cultured macrophages.
1990
Transitional features in human atherosclerosis. Intimal thickening, cholesterol clefts, and cell loss in human aortic fatty streaks.
1993
Alpha-Tocopherol Supplementation in Healthy Individuals Reduces Low-Density Lipoprotein Oxidation but Not Atherosclerosis
2002
Enzymatic modification of low density lipoprotein by purified lipoxygenase plus phospholipase A2 mimics cell-mediated oxidative modification
1988
Works of Alan Chait being referenced
Diabetes and Cardiovascular Disease
1999 Standout
Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice
2011
Diabetes and atherosclerosis: is there a role for hyperglycemia?
2008
Differences in the metabolism of oxidatively modified low density lipoprotein and acetylated low density lipoprotein by human endothelial cells: inhibition of cholesterol esterification by oxidatively modified low density lipoprotein.
1989
Safety and tolerability of simvastatin plus niacin in patients with coronary artery disease and low high-density lipoprotein cholesterol (The HDL Atherosclerosis Treatment Study)
2004
Interaction of native and modified low-density lipoproteins with extracellular matrix
2000
Lipoprotein lipase is synthesized by macrophage-derived foam cells in human coronary atherosclerotic plaques.
1992
Simvastatin and Niacin, Antioxidant Vitamins, or the Combination for the Prevention of Coronary Disease
2001
Identification of the principal proteoglycan-binding site in LDL. A single-point mutation in apo-B100 severely affects proteoglycan interaction without affecting LDL receptor binding.
1998
Human Atherosclerotic Intima and Blood of Patients with Established Coronary Artery Disease Contain High Density Lipoprotein Damaged by Reactive Nitrogen Species
2004
Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis.
1993
Anti-HMGB1 antibody reduces weight gain in mice fed a high-fat diet
2015
Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B
1993
Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. I. Is the extent of atherosclerosis related to resistance of LDL to oxidation?
1994
FREQUENCY OF RISK FACTORS FOR ISCHÆMIC HEART-DISEASE IN A HEALTHY BRITISH POPULATION
1974
A Randomized Control Trial of the Effects of a Comprehensive Risk Reduction Nutrition Program on Plasma Homocysteine Levels in Hypertensives with Associated Cardiovascular Risk Factors.
1996
The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells.
1987
Neovascular Expression of E-Selectin, Intercellular Adhesion Molecule-1, and Vascular Cell Adhesion Molecule-1 in Human Atherosclerosis and Their Relation to Intimal Leukocyte Content
1996
Secretion of a lipid transfer protein by human monocyte-derived macrophages.
1985
TYPE-III HYPERLIPOPROTEINÆMIA ("REMNANT REMOVAL DISEASE")
1977
Rationale of the diet-heart statement of the American Heart Association. Report of the Nutrition Committee.
1993
Severe hypertriglyceridemia: Role of familial and acquired disorders
1983
REGULATORY ROLE OF TRIIODOTHYRONINE IN THE DEGRADATION OF LOW DENSITY LIPOPROTEIN BY CULTURED HUMAN SKIN FIBROBLASTS
1979
Impaired Superoxide Production Due to a Deficiency in Phagocyte NADPH Oxidase Fails to Inhibit Atherosclerosis in Mice
2000
Regulatory role of insulin in the degradation of low density lipoprotein by cultured human skin fibroblasts
1978
Phagocytosis of aggregated lipoprotein by macrophages: low density lipoprotein receptor-dependent foam-cell formation.
1989
Lipid composition of aorta of Watanabe heritable hyperlipemic and comparably hypercholesterolemic fat-fed rabbits. Plasma lipid composition determines aortic lipid composition of hypercholesterolemic rabbits.
1988
Chylomicronemia syndrome.
1992
Impaired very low density lipoprotein and triglyceride removal in broad beta disease: Comparison with endogenous hypertriglyceridemia
1978
Lipoprotein lipase secretion by human monocyte-derived macrophages.
1982
Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemia
1980
Fatty streak expansion and maturation in Watanabe Heritable Hyperlipemic and comparably hypercholesterolemic fat-fed rabbits.
1987
Antioxidant Supplements Block the Response of HDL to Simvastatin-Niacin Therapy in Patients With Coronary Artery Disease and Low HDL
2001
Antioxidant vitamin supplementation and lipid peroxidation in smokers
1998
Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemia
1980
Superoxide initiates oxidation of low density lipoprotein by human monocytes.
1987
Oxidative susceptibility of low density lipoprotein subfractions is related to their ubiquinol-10 and alpha-tocopherol content.
1994
Antioxidant Vitamins and Lipid Therapy
2002
Dietary Antioxidants Inhibit Development of Fatty Streak Lesions in the LDL Receptor–Deficient Mouse
1998
Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture.
1984
Modification of low density lipoprotein by lipoprotein lipase or hepatic lipase induces enhanced uptake and cholesterol accumulation in cells.
1988
Apolipoprotein E localization in human coronary atherosclerotic plaques by in situ hybridization and immunohistochemistry and comparison with lipoprotein lipase.
1994
Acquired Hyperlipidemia (Secondary Dyslipoproteinemias)
1990
Oxidation-Specific Epitopes in Human Coronary Atherosclerosis Are Not Limited to Oxidized Low-Density Lipoprotein
1996
Human arterial wall cells secrete factors that are chemotactic for monocytes.
1983
Reduced Plasma Peroxyl Radical Trapping Capacity and Increased Susceptibility of LDL to Oxidation In Poorly Controlled IDDM
1994
Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit.
1989
Kobberling Type of Familial Partial Lipodystrophy
2003
The influence of the triglyceride content of low density lipoprotein on the interaction of apolipoprotein B-100 with cells.
1988
Platelet-derived growth factor stimulates activity of low density lipoprotein receptors.
1980
Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells.
1986
Oxidation of low density lipoprotein by thiols: superoxide-dependent and -independent mechanisms.
1993
Phagocytosis of lipase-aggregated low density lipoprotein promotes macrophage foam cell formation. Sequential morphological and biochemical events.
1991
Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM
1994
Heterogeneity of primary lipoprotein lipase deficiency
1980
Comparison of Apolipoprotein and Proteoglycan Deposits in Human Coronary Atherosclerotic Plaques
1998
Inhibition of Hypercholesterolemia-Induced Atherosclerosis in the Nonhuman Primate by Probucol
1995
Probucol treatment affects the cellular composition but not anti-oxidized low density lipoprotein immunoreactivity of plaques from Watanabe heritable hyperlipidemic rabbits.
1991
The influence of oxidatively modified low density lipoproteins on expression of platelet-derived growth factor by human monocyte-derived macrophages
1991